PFIZER revenue for the last year amounted to 280.30 T COP, the most of which — 274.89 T COP — came from its highest performing source at the moment, Biopharma, the year earlier bringing 221.65 T COP. The greatest contribution to the revenue figure was made by United States — last year it brought PFIZER 170.44 T COP, and the year before that — 104.99 T COP.